Biomarkers for Obstructive Apnea Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively detect obstructive apnea, a life-threatening condition that can lead to sudden death in epilepsy patients, due to the lack of specific indicators and understanding of the physiological mechanisms involved.
Innovation Solution
The development of biomarkers, including high frequency EMG signals superimposed on ECG signals and variations in R-R wave intervals, which can be used to detect obstructive apnea by analyzing respiratory artifacts and heart rate variability, allowing for early warning systems to prevent respiratory arrest.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional monitoring methods are used, then device complexity is reduced, but measurement precision for detecting obstructive apnea is insufficient
Solution Approach 1:
The patent extracts specific biomarkers (high frequency EMG signals superimposed on ECG, R-R wave interval variations) from complex physiological signals to detect obstructive apnea. This extraction approach enables precise detection by focusing on specific diagnostic features while filtering out irrelevant information, thereby improving measurement precision without requiring complete analysis of all physiological parameters.
Solution Approach 2:
The patent uses respiratory artifacts in ECG signals as an intermediary to detect airway obstruction. Instead of directly monitoring the airway, the system detects indirect manifestations (respiratory artifacts, EMG signals, heart rate variability) that serve as mediators for inferring the obstructive state, enabling detection through alternative pathways that improve precision.
2Measurement precision
If specific biomarkers for obstructive apnea are developed, then measurement precision is improved, but difficulty of detecting and measuring increases
Solution Approach 1:
The patent replaces direct mechanical or physiological measurement of airway obstruction with electrical signal analysis. By substituting electromagnetic methods (ECG, EMG signal processing) for direct mechanical monitoring, the system achieves specific biomarker detection while using computational algorithms to manage the complexity of signal analysis.
Solution Approach 2:
The patent changes the parameters being measured from general physiological indicators to specific frequency-domain characteristics (high frequency EMG components, R-R interval variability). This parameter transformation enables specific detection of obstructive apnea by focusing on particular signal characteristics that differentiate it from other respiratory conditions.
3Loss of time
If early warning systems are implemented, then loss of time for intervention is reduced, but device complexity increases
Solution Approach 1:
The patent implements preliminary detection by continuously monitoring biomarkers and comparing them against threshold values or baseline patterns. The system performs preliminary analysis of ECG and EMG signals to identify early signs of obstructive apnea before respiratory arrest occurs, enabling timely intervention through advance warning.
Solution Approach 2:
The patent employs feedback mechanisms where detected biomarkers trigger alerts or warnings to caregivers. The system continuously monitors physiological parameters, provides feedback when abnormal patterns are detected, and enables rapid response by immediately notifying medical personnel of potential obstructive apnea events.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These biomarkers provide a practical means to identify obstructive apnea, enabling timely intervention and potentially saving lives by alerting caregivers before respiratory arrest occurs.
Implementation Method 1
receiving a bioelectric signal from a mammal comprising electromyographic activity of muscles of respiration, including diaphragm and intercostal muscles
Implementation Method 2
variations in R-R wave intervals, which can be used to detect obstructive apnea by analyzing respiratory artifacts and heart rate variability
Data Source
AI summary
Two biomarkers are provided for obstructive apnea. A first biomarker determines amplitude and timing of inspiratory efforts from a bioelectric signal. The respiratory rate is compared with a normal pre-detection rate, and the amplitude of the effort is compared with a normal amplitude. The obstructive apnea is likely present if a series of inspiratory efforts are above a normal amplitude and with increasing amplitude, but at a normal rate. A second biomarker determines heart rate and respiratory rate. A normal lower threshold for heartbeat interval is established, and if subthreshold events occur (short RR intervals), a commencement time for each sequence of subthreshold events is compared for a respiratory rate-normalized window. If the number of subthreshold events exceeds a minimum for the window, obstructive apnea is likely present.